HC
BMY icon

Hendley & Co’s Bristol-Myers Squibb BMY Stock Holding History

Hendley & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-35,967
Closed -$2.17M – 70
2020
Q3 		$2.17M Sell
35,967
-1,335
-4% -$80.3K 0.9% 34
2020
Q2 		$2.19M Sell
37,302
-1,460
-4% -$87.3K 1.04% 34
2020
Q1 		$2.16M Buy
38,762
+540
+1% +$33K 1.21% 31
2019
Q4 		$2.45M Buy
+38,222
New +$2.19M 1.08% 36

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hendley & Co's BMY Position: Q4 2020 in Review

Hendley & Co sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 35,967 shares — an estimated $2.17M sold.

Hendley & Co first reported a position in BMY in Q4 2019 and held it in 4 quarters. The position peaked at $2.45M in Q4 2019. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Hendley & Co reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Hendley & Co sold 35,967 Bristol-Myers Squibb shares in Q4 2020, an estimated $2.17M.
  • Hendley & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 4 quarters.
  • Hendley & Co's Bristol-Myers Squibb position peaked at $2.45M in Q4 2019.
  • 2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Hendley & Co's 13F filing for Q4 2020, filed 19 Jan 2021.